# Effect of Agave Inulin Supplementation on Metabolic Profile and Intestinal Abundance of Bifidobacterium and Lactobacillaceae in Adults With Type 2 Diabetes Mellitus

> **NCT07696247** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Universidad Autonoma de Queretaro** · enrollment: 43 (actual)

## Conditions studied

- Type 2 Diabetes
- Gut Microbiota
- Insulin Resistance
- Metabolic Syndrome
- Prebiotic

## Interventions

- **DIETARY_SUPPLEMENT:** Agave Inulin
- **DIETARY_SUPPLEMENT:** Maltodextrin (Placebo)

## Key facts

- **NCT ID:** NCT07696247
- **Lead sponsor:** Universidad Autonoma de Queretaro
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2026-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07696247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07696247, "Effect of Agave Inulin Supplementation on Metabolic Profile and Intestinal Abundance of Bifidobacterium and Lactobacillaceae in Adults With Type 2 Diabetes Mellitus". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07696247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
